Product Overview
CJC-1295 without DAC is a modified analog of (GHRH 1-29) with four amino acid substitutions (at positions 2, 8, 15, and 27) designed to enhance stability against enzymatic degradation compared to native GHRH.
The product is provided as a sterile lyophilized powder, typically appearing as a white to off-white solid in a sealed vial.
Specifications (Typical)
• Active Ingredient: CJC-1295 without DAC – 10 mg per vial
• Synonyms: Modified GRF (1-29), tetrasubstituted GRF (1-29), CJC-1295 no DAC
• CAS Number: 446036-97-1 (or 863288-34-0 in some references)
• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: Approximately 3367.9 g/mol
• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
• Purity: ≥98–99% (verified by HPLC and other analytical methods; Certificate of Analysis typically available)
• Form: Lyophilized powder in a sterile glass vial
• Shelf Life: Typically 24 months when stored properly in lyophilized form
CJC-1295 w/o DAC_RUO 10mg
Price range: $115.00 through $999.00
CJC-1295 without DAC is a modified analog of (GHRH 1-29) with four amino acid substitutions (at positions 2, 8, 15, and 27) designed to enhance stability against enzymatic degradation compared to native GHRH.
The product is provided as a sterile lyophilized powder, typically appearing as a white to off-white solid in a sealed vial.
Intended Use Statement
This product is strictly for laboratory research use only (RUO). It is not intended, approved, or suitable for human consumption, animal use, clinical applications, diagnostic procedures, or any form of medical treatment. All handling, experimentation, and data interpretation must comply with applicable institutional, local, and federal regulations governing research chemicals.
No FAQs added for this product yet.






Reviews
There are no reviews yet.